JDP Successfully Completes Its Initial Phase 3 Clinical Trial of JDP-205 in Patients with Acute Urticaria Associated

Business & Finance Press Release Posted on , By

JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company has successfully completed the initial Phase 3 clinical trial (ETTAU-02)

148 0

0 Comments